Turnover: 3 billion USD (2021)
Country: Ireland
Jazz Pharmaceuticals is an Irish company operating within the pharmaceutical industry. Since 2021, the group has diversified into the production of medical cannabis, through the acquisition of GW Pharmaceuticals for $7.2 billion. This purchase enables them to market the flagship drug Epidiolex®, which treats epilepsy.
The group is pursuing a diversification strategy through the development of innovative therapies.
Studies mentioning this company
The CBD market - Spain
Other companies mentioned:
- justbob.fr
- Aurora Cannabis
- Canopy Growth
- Linneo Health
- Jazz Pharmaceuticals